Search research articles
Contact Us
Filters
Showing results (81-90 of 123) with videos related to
Page
of 13
Sort By:
Molecular Cancer Therapeutics
|
January 30, 2016
GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
Sandra Baumgart, Nai-Ming Chen, Jin-San Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2020
Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma
Siddhartha Yadav, Pashtoon M Kasi, William R Bamlet, et al.
Gastrointestinal Endoscopy
|
March 25, 2015
Impact of celiac neurolysis on survival in patients with pancreatic cancer
Larissa L Fujii-Lau, William R Bamlet, Jason S Eldrige, et al.
JAMA
|
June 21, 2018
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
Chunling Hu, Steven N Hart, Eric C Polley, et al.
Pancreas
|
December 10, 2015
Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis
Robert R McWilliams, Patrick Maisonneuve, William R Bamlet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2026
Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase 2 blinded biomarker validation and panel discovery study
Ann L Oberg, William R Bamlet, Grant Izmirlian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2021
High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9
Shounak Majumder, William R Taylor, Patrick H Foote, et al.
The Journal of Biological Chemistry
|
April 6, 2021
A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition
Isaac P Horn, David L Marks, Amanda N Koenig, et al.
Cancer Discovery
|
April 4, 2014
Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D
Sandra Baumgart, Nai-Ming Chen, Jens T Siveke, et al.
American Journal of Hematology
|
November 20, 2024
Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical Pilot
Thomas E Witzig, William R Taylor, Douglas W Mahoney, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 123) with videos related to
Sort By:
Page
of 13
Molecular Cancer Therapeutics
|
January 30, 2016
GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
Sandra Baumgart, Nai-Ming Chen, Jin-San Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2020
Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma
Siddhartha Yadav, Pashtoon M Kasi, William R Bamlet, et al.
Gastrointestinal Endoscopy
|
March 25, 2015
Impact of celiac neurolysis on survival in patients with pancreatic cancer
Larissa L Fujii-Lau, William R Bamlet, Jason S Eldrige, et al.
JAMA
|
June 21, 2018
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
Chunling Hu, Steven N Hart, Eric C Polley, et al.
Pancreas
|
December 10, 2015
Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis
Robert R McWilliams, Patrick Maisonneuve, William R Bamlet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2026
Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase 2 blinded biomarker validation and panel discovery study
Ann L Oberg, William R Bamlet, Grant Izmirlian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2021
High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9
Shounak Majumder, William R Taylor, Patrick H Foote, et al.
The Journal of Biological Chemistry
|
April 6, 2021
A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition
Isaac P Horn, David L Marks, Amanda N Koenig, et al.
Cancer Discovery
|
April 4, 2014
Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D
Sandra Baumgart, Nai-Ming Chen, Jens T Siveke, et al.
American Journal of Hematology
|
November 20, 2024
Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical Pilot
Thomas E Witzig, William R Taylor, Douglas W Mahoney, et al.
Page
of 13